Calidi Biotherapeutics, Inc. Convertible Notes Payable, Noncurrent
Calidi Biotherapeutics, Inc. (CLDI) had Convertible Notes Payable, Noncurrent of $1.77 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Notes and Loans, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2024-11-12
- 2024-09-30: Convertible Notes Payable, Noncurrent $1.77M.
- 2024-06-30: Convertible Notes Payable, Noncurrent $1.93M.
- 2024-03-31: Convertible Notes Payable, Noncurrent $3.38M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2024-09-30 | $1.77M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.93M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.38M 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |